India's ultra-rich class betting on luxury propertiesLuxury housing sales in Mumbai and Pune were the highest in four years in 2021 and may set a new record in 2022, according to a joint repor...
PharmEasy to acquire ThyrocareFrom Pharmeasy-Thyrocare deal to Twitter briefly locking IT minister's account and China's role in 2021's crypto collapse, here's a quick l...
Tata's neobanking pushIn today's ETtech Morning Dispatch, Tata Digital to add neobank to its super app, India's cryptocurrency industry attracts foreign funds, S...
Amazon, Flipkart challenge court orderFrom Amazon and Flipkart challenging HC order on CCI's antitrust probe to Twitter's standoff with govt and Satya Nadella elected as board c...
The SaaS gold rushIn today's ETtech Morning Dispatch newsletter: BrowserStack have become the most-valued Indian SaaS startup; Twitter's tussle wih the gover...
Online pharmacies are helping to lower health costs in IndiaWhat happened in general retail, with the entry of Flipkart, Amazon, is now happening in drug retail.
PharmEasy looks to hire 200 people in next three monthsThe Mumbai-based startup is looking to hire a little over 100 people for its technology team in the next two months, PharmEasy cofounder Dh...
Debt-ridden Elder Pharmaceuticals on the blockPromoters’ move to sell drug maker evokes interest from India’s large pharma companies and MNCs keen on gaining access to its three brands.
Elder Pharmaceuticals to invest Rs 20 crore for cosmetics forayElder Pharmaceuticals will be investing Rs 15-20 crore over the next two-three years for its foray into cosmetics manufacturing.
India, Russia strengthen ties via $4 bn defence dealsThe two nations inked 10 pacts in all, including two defence deals for aircraft, helicopter supplies, and three B2B deals for joint investm...
Indian, Russian Firms, including TCS, sign three pactsThese agreements were inked on the occasion of the visit of Russian President Vladimir Putin to India.
- Pharma sector gains from Re appreciation
The appreciation of the rupee might have brought in its share of woes for exporters and traders alike, but for the pharmaceutical sector wi...